Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxigen Biotech has developed and commercialized over 68 products based on collagen and hyaluronic acid for medical device applications across orthopedics, aesthetics, dental care, ophthalmology, ENT surgery, and general surgical wound care. Products have global regulatory approvals including CE mark and US FDA clearance. Revenue exceeded USD 20 million in 2022. No clinical trial pipeline as typical for drugs; instead focuses on regulatory-approved devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maxigen Biotech.